FGF21 Attenuates Pulmonary Arterial Hypertension via Downregulation of miR-130, Which Targets PPARγ

Using miRNA sequencing and real-time PCR, we found that fibroblast growth factor 21 (FGF21) treatment inhibited miR-130 elevation in hypoxia-induced PAH in vitro and in vivo.